1. Home >
  2. M&A >
  3. Growth Capital >
  4. United States >
  5. North Carolina >
  6. VSS Capital Partners Invests In Eximia

Investment Summary

VSS Capital Partners Invests In Eximia

On October 4, 2023, private equity firm VSS Capital Partners invested in life science company Eximia

Investment Highlights
  • This is VSS Capital Partners’ 1st transaction in the Life Science sector.
  • This is VSS Capital Partners’ 77th transaction in the United States.
  • This is VSS Capital Partners’ 1st transaction in North Carolina.

Investment Summary
Date 2023-10-04
Target Eximia
Sector Life Science
Investor(s) VSS Capital Partners
Deal Type Growth Capital

Target

Eximia

Raleigh, North Carolina, United States
Eximia is a multi-site, multi-therapeutic, clinical research site network serving pharmaceutical, biotech companies, and CROs and providing research services across a diverse range of therapeutic indications with access to underrepresented patient populations. Eximia is based in Raleigh, North Carolina.

Search 205,401 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

VSS Capital Partners

New York, New York, United States

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1987
PE ASSETS 4.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

VSS Capital Partners is a private equity firm that targets investments in the media, communications, education, and information services sectors. VSS looks for opportunities with valuable brand franchises, stable cash flows, and infrastructure to support add-ons. The Firm will consider businesses throughout North America and Europe valued between $50 and $750 million. Prospective investment situations include management buyouts/buy-ins, expansion or acquisition financings, recapitalizations, build-ups, going private transactions, and partnerships. VSS was formed in 1987 and is based in New York, New York.

DEAL STATS #
Overall 96 of 99
Sector (Life Science) 1 of 1
Type (Growth Capital) 23 of 26
State (North Carolina) 1 of 1
Country (United States) 77 of 79
Year (2023) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-07-18 Southern Theaters

New Orleans, Louisiana, United States

Southern Theatres develops and operates multiplex, stadium-seating movie theaters in small-to-midsized markets across the southeastern United States. Southern Theatres operates 36 locations with 433 screens in Alabama, Colorado, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, Ohio, Pennsylvania, South Carolina, Texas and Virginia. Southern Theaters was founded in 2002 and is based in New Orleans, Louisiana.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-08 QuadraNet

Los Angeles, California, United States

QuadraNet is a full-service data center provider one of the most well-regarded peering-exchanges locations. Their data center locations include the cities of Los Angeles, Dallas, Miami, Atlanta, Chicago, and New Jersey. QuadraNet’s exclusive services and large portfolio of services, all engineered and optimized with their proprietarily developed Intelligent Monitoring Platform (IMP) include infrastructure as a service (IaaS) deployments; colocation and data center space of all sizes; both managed services and remote hands services; public and private cloud service offerings; bespoke enterprise-architected solutions, and traditional dedicated services and IP Transit services that have high-capacity backbones world-wide. QuadraNet was formed in 2001 and is based in Los Angeles, California.

Sell -
Mergr

Product

Company

Legal